Alzamend Neuro, Inc.
ALZN· Nasdaq
ALZNAlzamend Neuro, Inc.
Filed Mar 11, 2026 · 10-Q · 39 days after period end · 0001214659-26-003166
| Metric | Q3 2026 | Q3 2025 | Q3 2024 | Q3 2023 |
|---|---|---|---|---|
| Net Income | -$2.20M | -$1.04M | -$2.66M | -$5.43M |
| EPS Diluted | -$0.58 | -$0.19 | -$3.77 | -$0.83 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Alzamend Neuro, Inc. · CIK 1677077 · Engraved from SEC EDGAR
ended Jan 31, 2026 · filed Mar 11, 2026 · 39 d after period end
